GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » ROIC %

Sphere Medical Holding (LSE:SPHR) ROIC % : -185.93% (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Sphere Medical Holding's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2016 was -185.93%.

As of today (2024-06-12), Sphere Medical Holding's WACC % is 0.00%. Sphere Medical Holding's ROIC % is -247.01% (calculated using TTM income statement data). Sphere Medical Holding earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Sphere Medical Holding ROIC % Historical Data

The historical data trend for Sphere Medical Holding's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding ROIC % Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
ROIC %
Get a 7-Day Free Trial Premium Member Only -2,992.26 -1,646.26 -2,716.08 -969.00 -221.01

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -3,033.73 -5,643.72 -730.15 -255.21 -185.93

Competitive Comparison of Sphere Medical Holding's ROIC %

For the Medical Devices subindustry, Sphere Medical Holding's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's ROIC % distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's ROIC % falls into.



Sphere Medical Holding ROIC % Calculation

Sphere Medical Holding's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2016 is calculated as:

ROIC % (A: Dec. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2015 ) + Invested Capital (A: Dec. 2016 ))/ count )
=-5.141 * ( 1 - 10.97% )/( (1.012 + 3.13)/ 2 )
=-4.5770323/2.071
=-221.01 %

where

Sphere Medical Holding's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2016 is calculated as:

ROIC % (Q: Dec. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2016 ) + Invested Capital (Q: Dec. 2016 ))/ count )
=-4.996 * ( 1 - 0% )/( (2.244 + 3.13)/ 2 )
=-4.996/2.687
=-185.93 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2016) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Sphere Medical Holding's WACC % is 0.00%. Sphere Medical Holding's ROIC % is -247.01% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Sphere Medical Holding ROIC % Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.